The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,988.00
Bid: 1,984.00
Ask: 1,993.00
Change: 28.00 (1.43%)
Spread: 9.00 (0.454%)
Open: 1,994.00
High: 2,000.00
Low: 1,988.00
Prev. Close: 1,960.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's FTSE holds close to two-month high

Wed, 21st Dec 2016 17:15

* FTSE 100 flat at close

* CCH up after Coca Cola buys AB InBev Africa bottling stake

* Ashtead gains following target price increase

* QinetiQ rises after deal for Meggitt defence unit (Recasts, adds quote and detail, updates prices at close)

By Kit Rees and Alistair Smout

LONDON, Dec 21 (Reuters) - Britain's top share index endedlittle changed on Wednesday after reaching a two-month high,though a rise in Ashtead Group and bottler Coca-ColaHellenic provided support.

The FTSE 100 was flat at 7,041.42 points at its close, withtrading volume low.

The index had touched a fresh two month high in early deals,having posted its highest close since October 11 in the previoussession.

Coca-Cola Hellenic (CCH) was up 1.3 percent afterCoca-Cola bought a majority stake in an African bottlingfirm from AB InBev for $3.15 billion.

Coca-Cola said it planned to hold all operations temporarilyuntil they can be refranchised to other partners. Its existingbottling partners include Coca-Cola European Partners andCoca-Cola Hellenic.

Analysts said that CCH was well positioned to secure thebottling rights due to its experience in Africa, and that thedeal looked like good value, coming in under expectations of $4billion or more.

Shares in Ashtead climbed 1.3 percent after CreditSuisse raised its target price for the stock, citing a boost forthe stock from its U.S. exposure.

"We raise our FY18E and FY19E estimates ... reflecting astronger demand outlook in the wake of the U.S. presidentialelection, along with some assumed benefit of a falling effectivetax rate on the group's dominant US activities," analysts atCredit Suisse said in a note.

Oil & gas stocks retreated 0.1 percent, withRoyal Dutch Shell down 0.4 percent after oil pricesedged lower on a surprise build in U.S. crude inventories.

Falls on the FTSE 100 were broad-based, with fund firmHargreaves Lansdown down 3 percent, health care stockHikma down 1.4 percent and Merlin Entertainments dropping 1.2 percent.

Capita fell after Goldman Sachs cut its target priceon the stock to 595p from 771p, but recovered some of its lossesto end 0.7 percent lower.

The investment bank said it expected free cash flow todecline around by about 3 percent each year for the next twoyears following Capita's recent trading update. Earlier in themonth the company gave its second profit warning in threemonths.

"In general, we see risks that the company's restructuringplan will not address the major concerns we have about biddingprocess and increasing cyclicality of the business model,"analysts at Goldman Sachs said in a note, reiterating a"neutral" rating on the stock.

Among mid-caps, QinetiQ was up 4.4 percent after itagreed to buy Meggitt's defence business. Liberum said the dealwould enhance QinetiQ's position in global test and aviationsectors. (Reporting by Alistair Smout and Kit Rees; Editing by AlisonWilliams)

More News
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 13:08

Jefferies downgrades Hikma to 'hold'

(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.

Read more
7 Nov 2023 09:28

LONDON BROKER RATINGS: Watches of Switzerland impresses HSBC; Asos cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 07:43

LONDON BRIEFING: AB Foods hails Primark; Beazley premiums rise

(Alliance News) - London's FTSE 100 is called to open in the red on Tuesday, following Asian equities lower, as the good feeling in equity markets after the softer US jobs data on Friday gives way to some caution.

Read more
6 Nov 2023 12:01

Berenberg stays at 'hold' on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.

Read more
3 Nov 2023 09:31

LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 Nov 2023 15:12

London close: Stocks rise as BoE keeps rates steady

(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.